KAIROS PHARMA LTD
Q3 2025 13F Holders
Symbol
KAPA
CUSIP
48301N104
Type
Equity
Class
COM
Num filings
14
Total reported value, excl. options
$506 k
Compare 2025 Q3 to
2026 Q2
2026 Q1
2025 Q4
2025 Q2
2025 Q1
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type